Synapse - Works

Results (5608)

A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancer

Journal Article

Fury, M. G.; Sherman, E.; Lisa, D.; Agarwal, N.; Algazy, K.; Brockstein, B.; Langer, C.; Lim, D. ; Mehra, R.; Rajan, S. K.; more...
Journal of the National Comprehensive Cancer Network (2012)

Fulltext@MSK | Save

12th Annual Meeting of the Society of Urologic Oncology (SUO) Bladder Cancer Sessions I and II summary report

Journal Article

Chang, S. S.; Dinney, C. P. N.; Donat, S. M.; Dahm, P.; Gore, J. L.; Lotan, Y.; Parekh, D. J.; Solit, D. B.; O'Donnell, P. H.; Feng, F. Y.; more...
Urologic Oncology: Seminars and Original Investigations (2012)

Fulltext@MSK | Save

Reduced proficiency in Homologous Recombination underlies the high sensitivity of embryonal carcinoma Testicular Germ Cell Tumors to cisplatin and poly (ADP-ribose) polymerase inhibition

Journal Article

Cavallo, F.; Graziani, G.; Antinozzi, C.; Feldman, D. R.; Houldsworth, J.; Bosl, G. J.; Chaganti, R. S. K.; Moynahan, M. E.; Jasin, M.; Barchi, M.
PLoS ONE (2012)

Fulltext@MSK | Save

Progression of RAS-mutant leukemia during RAF inhibitor treatment

Journal Article

Callahan, M. K.; Rampal, R.; Harding, J. J.; Klimek, V. M.; Chung, Y. R.; Merghoub, T.; Wolchok, J. D.; Solit, D. B.; Rosen, N.; Abdel-Wahab, O.; more...
New England Journal of Medicine (2012)

Fulltext@MSK | Save

Practical use of perioperative chemotherapy for muscle-invasive bladder cancer: Summary of session at the Society of Urologic Oncology annual meeting

Journal Article

Apolo, A. B.; Grossman, H. B.; Bajorin, D.; Steinberg, G.; Kamat, A. M.
Urologic Oncology: Seminars and Original Investigations (2012)

Fulltext@MSK | Save

ARN-509 in men with high risk non-metastatic castration-resistant prostate cancer

Meeting Abstract

Smith, M. R.; Antonarakis, E. S.; Ryan, C. J.; Berry, W.; Shore, N. D.; Liu, G.; Alumkal, J.; Higano, C.; Chow-Maneval, E.; Rathkopf, D.
Annals of Oncology (2012)

Fulltext@MSK | Save

Association of baseline corticosteroid with outcomes in a multivariate analysis of the phase 3 AFFIRM study of enzalutamide (ENZA), an androgen receptor signaling inhibitor (ARSI)

Meeting Abstract

Scher, H. I.; Fizazi, K.; Saad, F.; Chi, K.; Taplin, M.; Sternberg, C. N.; Armstrong, A. J.; Hirmand, M.; Selby, B.; de Bono, J. S.
Annals of Oncology (2012)

Fulltext@MSK | Save

Association of radiographic progression-free survival (rPFS) adapted from Prostate Cancer Working Group 2 (PCWG2) consensus criteria (APCWG2) with overall survival (OS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results from COU-AA-302

Meeting Abstract

Ryan, C. J.; Morris, M.; Molina, A.; Piulats, J. R.; De Souza, P.; Li, J.; Kheoh, T.; de Bono, J. S.; Larson, S.; Griffin, T.; more...
Annals of Oncology (2012)

Fulltext@MSK | Save

Genes, chromosomes and the treatment of bladder cancer

Meeting Abstract

Rosenberg, J. E.
Annals of Oncology (2012)

Fulltext@MSK | Save

Sunitinib treatment of renal adjuvant cancer (S-TRAC): A randomized, double-blind, phase III study of sunitinib vs. placebo in subjects at high risk of recurrent renal cell carcinoma (RCC)

Meeting Abstract

Ravaud, A.; Motzer, R. J.; Pandha, H.; Staehler, M.; George, D. J.; Pantuck, A.; Patel, A.; Gerletti, P.; Chen, L.; Patard, J.
Annals of Oncology (2012)

Fulltext@MSK | Save